opgn stock forecast zacks

Friday, August 12, 2022 Edit

Ad Our Suite of Platforms isnt Just Made For the Trading Obsessed - its Made by Them. Ad Our Suite of Platforms isnt Just Made For the Trading Obsessed - its Made by Them.

4 Penny Stocks To Buy According To Analysts Price Targets Up To 507

Now is the time to move.

. Explore Investment Resources Portfolios Market Commentary More at Zacks. On average they anticipate Aprea Therapeutics share price to reach 320 in the next twelve months. OpGen Announces Publication of Results from the Acuitas AMR Gene Panel Multicenter Clinical Trial in the Journal of Clinical Microbiology.

2 hours agoZacks Small Cap analyst D. According to 8 analysts the average rating for OPGN stock is Buy The 12-month stock price forecast is 187 which is an increase of 20161 from the latest price. Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the OPGN shares relative to the market in the.

Diversify your portfolio with guidance from investment professionals. NASDAQ Stock Exchange Healthcare Diagnostics Research Watchlist. Find the latest OpGen Inc.

Were thinking long term and doubling down on this stock. Technical indicators show current momentum could push these 5 stocks even higher. Ad These 5 companies are set for historic price action.

Report 062 065 Volume. OPGN delivered earnings and revenue surprises of 000 and -2267 respectively for the quarter ended June 2021. Access the Nasdaqs Largest 100 non-financial companies in a Single Investment.

Do the numbers hold clues to what lies. OPGN stock quote history news and other vital information to help you with your stock trading and investing. Ad Find Top Rated Stocks Information to Help You Beat the Market.

The 2 analysts offering 12-month price forecasts for OpGen Inc have a median target of 184 with a high estimate of 300 and a low estimate of 067. Their APRE stock forecasts range from 200 to 400. Use the IRA Selector tool to explore your options and see if youre eligible.

Bautz now forecasts that the biotechnology company will earn 138 per share for the year down from their previous forecast of 114. - Hold Zacks proprietary data indicates that OpGen Inc. Ad Worried about the market.

Stock Price Forecast The 2 analysts offering 12-month price forecasts for MBIA Inc have a median target of 1550 with a high estimate of 1800 and a low estimate of 1300. Ad See how Invesco QQQ ETF can fit into your portfolio. Stock Forecast NASDAQOPGN BUY.

Ad Learn what to consider between a Traditional Roth IRA.

Opgen To Provide Business Update And Financial Results For The First Quarter 2022 On May 12th At 4 30 P M Eastern Time